This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, Y Articles by Lee, W H Search for Related Content PubMed PubMed Citation Articles by Chen, Y Articles by Lee, W H

Hot-spot p53 mutants interact specifically with two cellular proteins during progression of the cell cycle.

Center for Molecular Medicine, University of Texas Health Science Center at San Antonio 78245.

ABSTRACT

Inactivation of both alleles of the p53 gene is commonly found in human cancers. In contrast to mutations of the retinoblastoma gene, certain altered forms of p53 gain growth-promoting functions. To explore the mechanisms underlying this gain of function, we have identified two nuclear proteins, with molecular masses of 42 and 38 kDa, respectively, that are specifically associated with p53 mutated within the simian virus 40 T-antigen-binding domain, "hot spots" found in many human tumors. These mutants transactivate the multiple-drug resistance gene promoter and cause cells to grow to higher density. Both the mutated p53 complex with p42 and p38 increase when cells enter S phase of the cell cycle but decrease in G1 and M phases, suggesting that they may have a role in promoting cell growth.

This article has been cited by other articles:

• Scian, M. J., Stagliano, K. E. R., Anderson, M. A. E., Hassan, S., Bowman, M., Miles, M. F., Deb, S. P., Deb, S. (2005). Tumor-Derived p53 Mutants Induce NF-{kappa}B2 Gene Expression. Mol. Cell. Biol. 25: 10097-10110 [Abstract] [Full Text]  
• O'Farrell, T. J., Ghosh, P., Dobashi, N., Sasaki, C. Y., Longo, D. L. (2004). Comparison of the Effect of Mutant and Wild-Type p53 on Global Gene Expression. Cancer Res. 64: 8199-8207 [Abstract] [Full Text]  
• van Oijen, M. G. C. T., Slootweg, P. J. (2000). Gain-of-Function Mutations in the Tumor Suppressor Gene p53. Clin. Cancer Res. 6: 2138-2145 [Abstract] [Full Text]  
• Hixon, M. L., Flores, A. I., Wagner, M. W., Gualberto, A. (1998). Ectopic Expression of cdc2/cdc28 Kinase Subunit Homo sapiens 1 Uncouples Cyclin B Metabolism from the Mitotic Spindle Cell Cycle Checkpoint. Mol. Cell. Biol. 18: 6224-6237 [Abstract] [Full Text]  
• Frazier, M. W., He, X., Wang, J., Gu, Z., Cleveland, J. L., Zambetti, G. P. (1998). Activation of c-myc Gene Expression by Tumor-Derived p53 Mutants Requires a Discrete C-Terminal Domain. Mol. Cell. Biol. 18: 3735-3743 [Abstract] [Full Text]  
• Ko, L J, Prives, C (1996). p53: puzzle and paradigm.. Genes Dev. 10: 1054-1072  
• Chen, Y., Chen, C.-F., Riley, D. J., Allred, D. C., Chen, P.-L., Von Hoff, D., Osborne, C. K., Lee, W.-H. (1995). Aberrant Subcellular Localization of BRCA1 in Breast Cancer. Science 270: 789-791 [Abstract]